BRAF-Mutant Metastatic Colorectal Cancer: Characteristics & Challenges

Host: Jennifer Caudle, DO <br> Guest: Dustin Deming, MD <br> <p>Dr Dustin Deming presents an overview of <em>BRAF</em>-mutant metastatic colorectal cancer (CRC). He reviews the incidence of and prognosis for <em>BRAF</em>-mutant metastatic CRC. Phenotypic characteristics and the molecular pathway associated with <em>BRAF</em>-mutant metastatic CRC are also discussed.</p> <p style="text-align: center;"> </p> <p style="text-align: left;">© 2021 Pfizer Inc. All rights reserved. PP-BCE-USA-0284 January 2021</p>